SAN FRANCISCO, October 27, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of ...
CLEVELAND--(BUSINESS WIRE)--Viscus Biologics, LLC, designer and manufacturer of allograft and xenograft extracellular matrix materials for biomedical applications, announces the launch of its new high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback